Login Register Cart 0
Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Adipose-derived Stem Cells: Potentials, Availability and Market Size in Regenerative Medicine

Author(s): Adele Soltani, Maryam Moradi, Aida Rezaei Nejad, Shabnam Moradi, Ehsan Javandoost, Hojjatollah Nazari and Arefeh Jafarian*

Volume 18, Issue 3, 2023

Published on: 26 August, 2022

Page: [347 - 379] Pages: 33

DOI: 10.2174/1574888X17666220413092750

Price: $65

Abstract

Adipose-derived stem cells (ADSCs) have been described as one of the most potent and accessible human adult stem cells which can be utilized in various therapeutic approaches. Due to the wide variety of cytokines and GFs secreted by them, ADSCs can be used for controlled drug release. These cells can be used for proliferation and differentiation of tissues regardless of survival conditions and immunologic problems. Because of their ability to differentiate into various lineages, ADSCs can be used in musculoskeletal problems, diabetes, heart diseases, obesity, neurologic and nephrogenic diseases, and wound healing, as well as applications in regenerative medicine such as osteogenic, cartilage, tendon, muscle, skin, CNS, cardiac and vascularization, as well as liver and even periodontal regeneration.

To maintain the highest viability and efficiency, companies that provide ADSCs should offer the best product quality to gain market share and scientists need to acquire an understanding of sources where they can find the best products available. Therefore, in this article, we have reviewed the available products, companies and the market size currently available for ADSCs. Enormous effort has been made to list the most important trials, products and companies currently existent in the field. To achieve better outcomes in scientific research, there is the need to compare the products available and choose the best option according to desired goals. Thus, this paper provides a valuable reference for those interested in the field of ADSCs and their applications.

Keywords: ADSCs, market size, regenerative medicine, clinical trials, stromal-vascular fraction (SVF), vascular endothelial growth factor (VEGF).

« Previous Next »
Graphical Abstract

[1]
Grasys J, Kim B-S, Pallua N. Content of soluble factors and characteristics of stromal vascular fraction cells in lipoaspirates from different subcutaneous adipose tissue depots. Aesthet Surg J 2016; 36(7): 831-41.
[http://dx.doi.org/10.1093/asj/sjw022] [PMID: 26906346]
[2]
Gaur M, Dobke M, Lunyak VV. Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging. Int J Mol Sci 2017; 18(1): 208.
[http://dx.doi.org/10.3390/ijms18010208] [PMID: 28117680]
[3]
Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep 2011; 7(2): 269-91.
[http://dx.doi.org/10.1007/s12015-010-9193-7] [PMID: 20853072]
[4]
Bajek A, Gurtowska N, Olkowska J, Kazmierski L, Maj M, Drewa T. Adipose-derived stem cells as a tool in cell-based therapies. Arch Immunol Ther Exp (Warsz) 2016; 64(6): 443-54.
[http://dx.doi.org/10.1007/s00005-016-0394-x] [PMID: 27178663]
[5]
Zhao Q, Ren H, Han ZJ. Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. Arch Immunol Ther Exp (Warsz) 2016; 2(1): 3-20.
[6]
Tabatabaei Qomi R, Sheykhhasan M. Adipose-derived stromal cell in regenerative medicine: A review. World J Stem Cells 2017; 9(8): 107-17.
[http://dx.doi.org/10.4252/wjsc.v9.i8.107] [PMID: 28928907]
[7]
Gir P, Oni G, Brown SA, Mojallal A, Rohrich RJ. Human adipose stem cells: Current clinical applications. Plast Reconstr Surg 2012; 129(6): 1277-90.
[http://dx.doi.org/10.1097/PRS.0b013e31824ecae6] [PMID: 22634645]
[8]
Sterodimas A, de Faria J, Nicaretta B, Pitanguy I. Tissue engineering with adipose-derived stem cells (ADSCs): Current and future applications. J Plast Reconstr Aesthet Surg 2010; 63(11): 1886-92.
[http://dx.doi.org/10.1016/j.bjps.2009.10.028] [PMID: 19969517]
[9]
Hong SJ, Jia S-X, Xie P, et al. Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS One 2013; 8(1)e55640
[http://dx.doi.org/10.1371/journal.pone.0055640] [PMID: 23383253]
[10]
Kilroy GE, Foster SJ, Wu X, et al. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212(3): 702-9.
[http://dx.doi.org/10.1002/jcp.21068] [PMID: 17477371]
[11]
Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010; 69(1): 241-8.
[http://dx.doi.org/10.1136/ard.2008.101881] [PMID: 19124525]
[12]
Gimble JM, Grayson W, Guilak F, Lopez MJ, Vunjak-Novakovic G. Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci (Schol Ed) 2011; 3(1): 69-81.
[http://dx.doi.org/10.2741/s133] [PMID: 21196358]
[13]
Lin L, Fu X, Zhang X, et al. Rat adipose-derived stromal cells expressing BMP4 induce ectopic bone formation in vitro and in vivo. Acta Pharmacol Sin 2006; 27(12): 1608-15.
[http://dx.doi.org/10.1111/j.1745-7254.2006.00449.x] [PMID: 17112416]
[14]
Shevchenko EK, Makarevich PI, Tsokolaeva ZI, et al. Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle. J Transl Med 2013; 11(1): 138.
[http://dx.doi.org/10.1186/1479-5876-11-138] [PMID: 23742074]
[15]
Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: Follow-up with trichograms. Eplasty 2015; 15e10
[PMID: 25834689]
[16]
Ramdasi S, Tiwari SK. Human mesenchymal stem cell-derived conditioned media for hair regeneration applications. J Stem Cells 2016; 11(4): 201-11.
[PMID: 28296872]
[17]
Yang Y, Choi H, Seon M, Cho D, Bang SI. LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway. Stem Cell Res Ther 2016; 7(1): 58.
[http://dx.doi.org/10.1186/s13287-016-0313-4] [PMID: 27095351]
[18]
Yiou R, Mahrouf-Yorgov M, Trébeau C, et al. Delivery of human mesenchymal adipose-derived stem cells restores multiple urological dysfunctions in a rat model mimicking radical prostatectomy damages through tissue-specific paracrine mechanisms. Stem Cells 2016; 34(2): 392-404.
[http://dx.doi.org/10.1002/stem.2226] [PMID: 26439006]
[19]
Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449(7162): 557-63.
[http://dx.doi.org/10.1038/nature06188] [PMID: 17914389]
[20]
Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sci 2020; 256118002
[http://dx.doi.org/10.1016/j.lfs.2020.118002] [PMID: 32585248]
[21]
Tsiapalis D, O’Driscoll L. Mesenchymal stem cell derived extracellular vesicles for tissue engineering and regenerative medicine applications. Cells 2020; 9(4): 991.
[http://dx.doi.org/10.3390/cells9040991] [PMID: 32316248]
[22]
Prichard HL, Reichert W, Klitzman B. IFATS collection: Adipose-derived stromal cells improve the foreign body response. Stem Cells 2008; 26(10): 2691-5.
[http://dx.doi.org/10.1634/stemcells.2008-0140] [PMID: 18436858]
[23]
Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129(1): 118-29.
[http://dx.doi.org/10.1111/j.1365-2141.2005.05409.x] [PMID: 15801964]
[24]
Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007; 13(6): 1185-95.
[http://dx.doi.org/10.1089/ten.2006.0315] [PMID: 17518704]
[25]
Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: Soluble factors and their roles in regenerative medicine. Curr Stem Cell Rep 2010; 5(2): 103-10.
[http://dx.doi.org/10.2174/157488810791268564] [PMID: 19941460]
[26]
Bertolini F, Lohsiriwat V, Petit J-Y, Kolonin MG. Adipose tissue cells, lipotransfer and cancer: A challenge for scientists, oncologists and surgeons. Biochim Biophys Acta 2012; 1826(1): 209-14.
[PMID: 22546620]
[27]
Levi B, Longaker MT. Concise review: Adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells 2011; 29(4): 576-82.
[http://dx.doi.org/10.1002/stem.612] [PMID: 21305671]
[28]
Tai G, Polak JM, Bishop AE, Christodoulou I, Buttery LD. Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcriptional factor osterix. Tissue Eng 2004; 10(9-10): 1456-66.
[http://dx.doi.org/10.1089/ten.2004.10.1456] [PMID: 15588405]
[29]
Cao L, Wang J, Hou J, Xing W, Liu C. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2. Biomaterials 2014; 35(2): 684-98.
[http://dx.doi.org/10.1016/j.biomaterials.2013.10.005] [PMID: 24140042]
[30]
Marenzana M, Arnett TR. The key role of the blood supply to bone. Bone Res 2013; 1(3): 203-15.
[http://dx.doi.org/10.4248/BR201303001] [PMID: 26273504]
[31]
Paduano F, Marrelli M, Amantea M, et al. Adipose tissue as a strategic source of mesenchymal stem cells in bone regeneration: A topical review on the most promising craniomaxillofacial applications. Int J Mol Sci 2017; 18(10): 2140.
[http://dx.doi.org/10.3390/ijms18102140] [PMID: 29027958]
[32]
Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int 2012; 2012812693
[http://dx.doi.org/10.1155/2012/812693] [PMID: 22577397]
[33]
Naderi N, Combellack EJ, Griffin M, et al. The regenerative role of adipose-derived stem cells (ADSC) in plastic and reconstructive surgery. Int Wound J 2017; 14(1): 112-24.
[http://dx.doi.org/10.1111/iwj.12569] [PMID: 26833722]
[34]
Gonçalves AI, Gershovich PM, Rodrigues MT, Reis RL, Gomes ME. Human adipose tissue-derived tenomodulin positive subpopulation of stem cells: A promising source of tendon progenitor cells. J Tissue Eng Regen Med 2018; 12(3): 762-74.
[http://dx.doi.org/10.1002/term.2495] [PMID: 28593712]
[35]
James R, Kumbar SG, Laurencin CT, Balian G, Chhabra AB. Tendon tissue engineering: Adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems. Biomed Mater 2011; 6(2)025011
[http://dx.doi.org/10.1088/1748-6041/6/2/025011] [PMID: 21436509]
[36]
Vieira NM, Brandalise V, Zucconi E, et al. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biol Cell 2008; 100(4): 231-41.
[http://dx.doi.org/10.1042/BC20070102] [PMID: 17997718]
[37]
Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and a literature review. J Nippon Med Sch 2009; 76(2): 56-66.
[http://dx.doi.org/10.1272/jnms.76.56] [PMID: 19443990]
[38]
Klar AS, Zimoch J, Biedermann T. Skin tissue engineering: Application of adipose-derived stem cells Biomed Res Int 2017; 201 2017. http://dx.doi.org/10.1155/2017/9747010
[39]
Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007; 119(5): 1409-22.
[http://dx.doi.org/10.1097/01.prs.0000256047.47909.71] [PMID: 17415234]
[40]
Chawla R, Tan A, Ahmed M, et al. A polyhedral oligomeric silsesquioxane-based bilayered dermal scaffold seeded with adipose tissue-derived stem cells: In vitro assessment of biomechanical properties. J Surg Res 2014; 188(2): 361-72.
[http://dx.doi.org/10.1016/j.jss.2014.01.006] [PMID: 24507201]
[41]
Lu W, Yu J, Zhang Y, et al. Mixture of fibroblasts and adipose tissue-derived stem cells can improve epidermal morphogenesis of tissue-engineered skin. Cells Tissues Organs 2012; 195(3): 197-206.
[http://dx.doi.org/10.1159/000324921] [PMID: 21494022]
[42]
Monfort A, Soriano-Navarro M, García-Verdugo JM, Izeta A. Production of human tissue-engineered skin trilayer on a plasma-based hypodermis. J Tissue Eng Regen Med 2013; 7(6): 479-90.
[http://dx.doi.org/10.1002/term.548] [PMID: 22294482]
[43]
Schäffler A, Büchler C. Concise review: Adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25(4): 818-27.
[http://dx.doi.org/10.1634/stemcells.2006-0589] [PMID: 17420225]
[44]
Sowa Y, Imura T, Numajiri T, Nishino K, Fushiki S. Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: Influence of age and anatomic site of origin. Stem Cells Dev 2012; 21(11): 1852-62.
[http://dx.doi.org/10.1089/scd.2011.0403] [PMID: 22150084]
[45]
Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007; 25(12): 3234-43.
[http://dx.doi.org/10.1634/stemcells.2007-0388] [PMID: 17901400]
[46]
Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001; 33(3): 379-93.
[http://dx.doi.org/10.1006/jmcc.2000.1329] [PMID: 11181008]
[47]
Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109(10): 1292-8.
[http://dx.doi.org/10.1161/01.CIR.0000121425.42966.F1] [PMID: 14993122]
[48]
Sadat S, Gehmert S, Song Y-H, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 2007; 363(3): 674-9.
[http://dx.doi.org/10.1016/j.bbrc.2007.09.058] [PMID: 17904522]
[49]
Marycz K. Szłapka-Kosarzewska J, Geburek F, Kornicka-Garbowska K. Systemic administration of rejuvenated adipose-derived mesenchymal stem cells improves liver metabolism in equine metabolic syndrome (EMS)-new approach in veterinary regenerative medicine. Stem Cell Rev Rep 2019; 15(6): 842-50.
[http://dx.doi.org/10.1007/s12015-019-09913-3] [PMID: 31620992]
[50]
Lemaitre M, Monsarrat P, Blasco-Baque V, et al. Periodontal tissue regeneration using syngeneic adipose‐derived stromal cells in a mouse model. Stem Cells Transl Med 2017; 6(2): 656-65.
[http://dx.doi.org/10.5966/sctm.2016-0028] [PMID: 28191762]
[51]
Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3(3): 301-13.
[http://dx.doi.org/10.1016/j.stem.2008.07.003] [PMID: 18786417]
[52]
Tabit CJ, Slack GC, Fan K, Wan DC, Bradley JP. Fat grafting versus adipose-derived stem cell therapy: Distinguishing indications, techniques, and outcomes. Aesthetic Plast Surg 2012; 36(3): 704-13.
[http://dx.doi.org/10.1007/s00266-011-9835-4] [PMID: 22069062]
[53]
Coleman SR. Structural fat grafting: More than a permanent filler. Plast Reconstr Surg 2006; 118(3) (Suppl.): 108S-20S.
[http://dx.doi.org/10.1097/01.prs.0000234610.81672.e7] [PMID: 16936550]
[54]
Nishimura T, Hashimoto H, Nakanishi I, Furukawa M. Microvascular angiogenesis and apoptosis in the survival of free fat grafts. Laryngoscope 2000; 110(8): 1333-8.
[http://dx.doi.org/10.1097/00005537-200008000-00021] [PMID: 10942136]
[55]
Tremolada C, Palmieri G, Ricordi C. Adipocyte transplantation and stem cells: Plastic surgery meets regenerative medicine. Cell Transplant 2010; 19(10): 1217-23.
[http://dx.doi.org/10.3727/096368910X507187] [PMID: 20444320]
[56]
Agostini T, Lazzeri D, Pini A, et al. Wet and dry techniques for structural fat graft harvesting: Histomorphometric and cell viability assessments of lipoaspirated samples. Plast Reconstr Surg 2012; 130(2): 331e-9e.
[http://dx.doi.org/10.1097/PRS.0b013e3182589f76] [PMID: 22495217]
[57]
Prodromos C, Rumschlag T. Administration of Autologous Mesenchymal Cells for the Treatment of Arthritis. Curr Stem Cell Res Ther 2021; 16(8): 931-8.
[http://dx.doi.org/10.2174/1574888X16666210224145104] [PMID: 33655846]
[58]
Freitag J, Bates D, Wickham J, et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: A randomized controlled trial. Regen Med 2019; 14(3): 213-30.
[http://dx.doi.org/10.2217/rme-2018-0161] [PMID: 30762487]
[59]
Alentorn-Geli E, Seijas R, Martínez-De la Torre A, et al. Effects of autologous adipose-derived regenerative stem cells administered at the time of anterior cruciate ligament reconstruction on knee function and graft healing. J Orthop Surg (Hong Kong) 2019; 27(3): 2309499019867580.
[http://dx.doi.org/10.1177/2309499019867580] [PMID: 31470759]
[60]
Tarallo M, Fino P, Ribuffo D, et al. Liposuction aspirate fluid adipose-derived stem cell injection and secondary healing in fingertip injury: A pilot study. Plast Reconstr Surg 2018; 142(1): 136-47.
[http://dx.doi.org/10.1097/PRS.0000000000004506] [PMID: 29649060]
[61]
Kim YS, Sung CH, Chung SH, Kwak SJ, Koh YG. Does an injection of adipose-derived mesenchymal stem cells loaded in fibrin glue influence rotator cuff repair outcomes? A clinical and magnetic resonance imaging study. Am J Sports Med 2017; 45(9): 2010-8.
[http://dx.doi.org/10.1177/0363546517702863] [PMID: 28448728]
[62]
Charles-de-Sá L, Gontijo-de-Amorim NF, Rigotti G, et al. Photoaged skin therapy with adipose-derived stem cells. Plast Reconstr Surg 2020; 145(6): 1037e-49e.
[http://dx.doi.org/10.1097/PRS.0000000000006867] [PMID: 32459770]
[63]
Narita K, Fukuoka H, Sekiyama T, Suga H, Harii K. Sequential scalp assessment in hair regeneration therapy using an adipose-derived stem cell–conditioned medium. Dermatol Surg 2020; 46(6): 819-25.
[http://dx.doi.org/10.1097/DSS.0000000000002128] [PMID: 31490301]
[64]
Raposio E, Bertozzi N, Bonomini S, et al. Adipose-derived stem cells added to platelet-rich plasma for chronic skin ulcer therapy. Wounds 2016; 28(4): 126-31.
[PMID: 27071140]
[65]
Abou Eitta RS, Ismail AA, Abdelmaksoud RA, Ghezlan NA, Mehanna RA. Evaluation of autologous adipose-derived stem cells vs. fractional carbon dioxide laser in the treatment of post acne scars: A split-face study. Int J Dermatol 2019; 58(10): 1212-22.
[http://dx.doi.org/10.1111/ijd.14567] [PMID: 31297798]
[66]
Chu DT, Nguyen Thi Phuong T, Tien NLB, et al. Adipose tissue stem cells for therapy: An update on the progress of isolation, culture, storage, and clinical application. J Clin Med 2019; 8(7)E917
[http://dx.doi.org/10.3390/jcm8070917] [PMID: 31247996]
[67]
Patrikoski M, Mannerström B, Miettinen S. Perspectives for clinical translation of adipose stromal/stem cells. Stem Cells Int 2019; 2019: 5858247.
[http://dx.doi.org/10.1155/2019/5858247] [PMID: 31191677]
[68]
Blazquez R, Sanchez-Margallo FM, de la Rosa O, et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol 2014; 5(556): 556.
[http://dx.doi.org/10.3389/fimmu.2014.00556] [PMID: 25414703]
[69]
Zhao H, Shang Q, Pan Z, et al. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing m2 macrophages and beiging in white adipose tissue. Diabetes 2018; 67(2): 235-47.
[http://dx.doi.org/10.2337/db17-0356] [PMID: 29133512]
[70]
Przekora A, Vandrovcova M, Travnickova M, et al. Evaluation of the potential of chitosan/β-1,3-glucan/hydroxyapatite material as a scaffold for living bone graft production in vitro by comparison of ADSC and BMDSC behaviour on its surface. Biomed Mater 2017; 12(1)015030
[http://dx.doi.org/10.1088/1748-605X/aa56f9] [PMID: 28054934]
[71]
Zaw Thin M, Allan H, Bofinger R, et al. Multi-modal imaging probe for assessing the efficiency of stem cell delivery to orthotopic breast tumours. Nanoscale 2020; 12(31): 16570-85.
[http://dx.doi.org/10.1039/D0NR03237A] [PMID: 32749427]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy